Health systems and providers are our Partners—especially those in underserved communities, with patients who merit the same access to leading-edge trials as those who live near national treatment centers.
To back this belief, GRN combines our national data system with clinical expertise. This expands options for patients and generates revenue to support your mission.
Access powerful eligibility technology for trial matching
Identify eligible patients for studies combining the best of technology and humanity—including proprietary trial matching software and our proven clinical validation.
Identify 100% of those eligible with our no-patient-left-behind approach
Meticulously “read” files using proprietary NLP and AI/ML
Quickly track trial candidates via cloud-based, communications portal
Easily share study protocols, patient notes and enrollment information
Add GRN resources to perform pre-study feasibility
Augment your clinical research staff
Powerful technology for trial matching & diagnostic studies
Use deep real world data and sophisticated analytics
Access more than 2 million potential patients and secure data that goes well beyond traditional EMR/EHRs to include:
Tumor morphology and histology
Labs, specialized tests and imaging
Advanced & molecular biomarkers
Genetic profiles & genomic sequencing
First, second, third line, etc., course of treatment
Patient characteristics and status
Tele-health, pharmacy and insurance details
Deep data, data science (RWD) & sophisticated analytics
Optimize the mountain of real world data available with real-time data science analytics, including:
Discrete data queries
Biostatistical algorithms
Virtual/external comparators
Natural Language Processing (NLP)
Artificial Intelligence/Machine Learning (AI/ML)
Cohort outcomes analysis
Cohorts for all of clinical studies saved, GRN and others
Leverage precision medicine tissue and blood studies
Access precision medicine trials from cutting-edge diagnostic companies as a new frontier for Partners. Employ curated datasets of surgical tissue and molecular profile data leveraging tissue as a value-enhancing asset.
Access member-only NGS resources, e.g. precision medicine database
Build on our pioneering reputation using precision medicine and surgical specimens linked with clinical data
Optimize prospectively consented specimens collected under a distinct IRB protocol
Minimize resources depending on tissue handling requirements
Ease enrollment with fewer time demands on physicians
Precision Medicine - Tissue/blood diagnostic studies